Understanding EGFR heterogeneity in lung cancer

The advances in understanding the inherited biological mechanisms of non-small cell lung cancer harbouring epidermal growth factor receptor (EGFR) mutations led to a significant improvement in the outcomes of patients treated with EGFR tyrosine kinase inhibitors. Despite these clinically impressive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:ESMO Open
Autores principales: Passaro, Antonio, Malapelle, Umberto, Del Re, Marzia, Attili, Ilaria, Russo, Alessandro, Guerini-Rocco, Elena, Fumagalli, Caterina, Pisapia, Pasquale, Pepe, Francesco, De Luca, Caterina, Cucchiara, Federico, Troncone, Giancarlo, Danesi, Romano, Spaggiari, Lorenzo, De Marinis, Filippo, Rolfo, Christian
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569934/
https://ncbi.nlm.nih.gov/pubmed/33067323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000919
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares